Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Biliary tract infections treated with ciprofloxacin

Autor: Karachalios, G. N., Zografos, G., Patrikakos, V., Nassopoulou, D., Kehagioglou, K.

Publikováno v: Infection; July 1993, Vol. 21 Issue: 4 p262-264, 3p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The effect of tibolone on women’s lipid profile with postime-nopausal osteoporosis

Autor: Petrogiannopoulos, C., Zaharof, A., Tzoumani, A., Panagopoulos, J., Kehagioglou, K., Poulikakos, J.

Publikováno v: Osteoporosis International; January 1996, Vol. 6 Issue: Supplement 1 p221-221, 1p

Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial

Autor: Cook, Audrey, Beesley, Sharon, O'Sullivan, Joe M, Birtle, Alison J, Thalmann, George, Graham, John D, Spears, Melissa R, Brock, Susannah, Srinivasan, Rajaguru, Protheroe, Andrew, Sydes, Matthew R, Laing, Robert, Cross, William, Matheson, David, Tsang, David, Parmar, Mahesh K B, Sundar, Santhanam, McKinna, Fiona, Parikh, Omi, Chowdhury, Simon, Robinson, Angus J, De Bono, Johann, Elliott, Tony, Mason, Malcolm D, Parker, Christopher C, Alzouebi, Mymoona, Gibbs, Stephanie, Dearnaley, David P, Millman, Robin, Russell, J Martin, Tolan, Shaun, Chakraborti, Prabir, Cathomas, Richard, Srihari, Narayanan, Clarke, Noel W, Peedell, Clive, James, Nicholas D, Staffurth, John, Gale, Joanna, Hetherington, John, Amos, Claire, Attard, Gerhardt, Hughes, Robert, Jones, Rob J, Ritchie, Alastair W S, McLaren, Duncan B, Wagstaff, John

Publikováno v: James, N D, Sydes, M R, Clarke, N W, Mason, M D, Dearnaley, D P, Spears, M R, Ritchie, A W S, Parker, C C, Russell, J M, Attard, G, de Bono, J, Cross, W, Jones, R J, Thalmann, G, Amos, C, Matheson, D, Millman, R, Alzouebi, M, Beesley, S, Birtle, A J, Brock, S, Cathomas, R, Chakraborti, P, Chowdhury, S, Cook, A, Elliott, T, Gale, J, Gibbs, S, Graham, J D, Hetherington, J, Hughes, R, Laing, R, McKinna, F, McLaren, D B, O'Sullivan, J M, Parikh, O, Peedell, C, Protheroe, A, Robinson, A J, Srihari, N, Srinivasan, R, Staffurth, J, Sundar, S, Tolan, S, Tsang, D, Wagstaff, J, Parmar, M K B & STAMPEDE investigators 2016, ' Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial ', Lancet, vol. 387, no. 10024, pp. 1163–1177 . https://doi.org/10.1016/S0140-6736(15)01037-5
Lancet (London, England), vol. 387, no. 10024, pp. 1163-1177
Lancet, vol. 387, no. 10024, pp. 1163-1177
James, Nicholas D; Sydes, Matthew R; Clarke, Noel W; Mason, Malcolm D; Dearnaley, David P; Spears, Melissa R; Ritchie, Alastair W S; Parker, Christopher C; Russell, J Martin; Attard, Gerhardt; de Bono, Johann; Cross, William; Jones, Rob J; Thalmann, George; Amos, Claire; Matheson, David; Millman, Robin; Alzouebi, Mymoona; Beesley, Sharon; Birtle, Alison J; ... (2016). Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial. Lancet, 387(10024), pp. 1163-1177. Elsevier 10.1016/S0140-6736(15)01037-5

BACKGROUND: Long-term hormone therapy has been the standard of care for advanced prostate cancer since the 1940s. STAMPEDE is a randomised controlled trial using a multiarm, multistage platform design. It recruits men with high-risk, locally advanced

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::262e0622007f03a2f7ea0b9d0272734e